Vox Markets Logo
26th November 2021
07:00

Silence Therapeutics - Update on AIM Delisting

25th November 2021
17:30

FTSE Russell - Silence Therapeutics

16th November 2021
07:00

Silence Therapeutics - Third Quarter 2021 Financial Results

11th November 2021
07:00

Silence Therapeutics - Silence to Present at Jefferies London Conference

11th November 2021
07:00

Silence Therapeutics - Silence to Present at Jefferies London Conference

10th November 2021
07:00

Silence Therapeutics - Holding(s) in Company

5th November 2021
07:00

Silence Therapeutics - New Key Shareholder

1st November 2021
17:33

Silence Therapeutics - Result of General Meeting

1st November 2021
16:49

Silence Therapeutics - Total Voting Rights

28th October 2021
15:02

Silence Therapeutics - Holding(s) in Company

21st October 2021
12:30

Silence Therapeutics - Silence Provides Pipeline Updates at 2021 R&D Day

15th October 2021
06:05

Silence Therapeutics - Proposed Cancellation of Trading on AIM

15th October 2021
06:00

Silence Therapeutics - Silence and Hansoh Pharma Announce Collaboration

8th October 2021
06:00

Silence Therapeutics - Block Listing Return

8th October 2021
06:00

Silence Therapeutics - Total Voting Rights

7th October 2021
06:00

Silence Therapeutics - Silence Therapeutics to host R&D day

28th September 2021
06:00

Silence Therapeutics - Chardan Genetic Medicines Conference Participation

8th September 2021
15:03

Silence Therapeutics - Holding(s) in Company

Silence Therapeutics Plc (SLN.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    78.37M

Silence Therapeutics Plc Company Profile

Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Watchlist